- Safety data consistent with prior brepocitinib clinical trials
- No new safety signals or findings identified
Roivant Sciences reported that safety data from brepocitinib clinical trials are consistent with prior studies, with no new safety signals or findings identified.
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.